Sanchez Ramiro

SEC Form 4 insider trading activity

Sanchez Ramiro has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Oct 23, 2026.

On the most recent filing, Sanchez Ramiro is listed as Director at Rapport Therapeutics, Inc. Inside the rolling window, Sanchez Ramiro reported 1 open-market purchase totaling $98K in RAPP and no open-market sales.

Companies traded

Other insiders at RAPP

Insider Buying

$98K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
RAPP
Sanchez Ramiro
Purchase$98KOct 23SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Sanchez Ramiro made?

Sanchez Ramiro has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.

Which companies does Sanchez Ramiro trade?

Sanchez Ramiro has filed SEC Form 4 disclosures for 1 company, including RAPP.

When was Sanchez Ramiro's most recent SEC Form 4 filing?

Sanchez Ramiro's most recent SEC Form 4 filing on Tracefour is dated Oct 23, 2026.

What is Sanchez Ramiro's total buy and sell value in the current window?

Inside the rolling retention window, Sanchez Ramiro bought $98K and sold $0 based on SEC Form 4 filings.

What was Sanchez Ramiro's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 3,600 RAPP shares on 2026-10-23, worth $98K, per SEC Form 4 filings.